[Use of micronucleus tests for screening mutagens and carcinogens]

L P Sycheva1, V S Zhukov

  • 1NII of Human Ecology and Environmental Hygiene RAMN, Moscow.

Insights

The micronucleus test in various organs effectively identified carcinogens, showing organ-specific effects. This method aids in detecting potential mutagens and carcinogens in mammals.

Area of Science:

  • Toxicology
  • Genetics
  • Carcinogenesis

Context:

  • Micronucleus formation is a biomarker of genotoxicity.
  • Chemical carcinogens exhibit varying organ tropism.
  • Assessing genotoxicity across multiple organs is crucial for understanding chemical effects.

Purpose:

  • To investigate the organ specificity of micronucleus induction by seven carcinogens in mice and rats.
  • To evaluate the correlation between mutagenic and carcinogenic properties of chemicals.
  • To propose the micronucleus test in various organs for detecting potential carcinogens.

Summary:

  • Seven carcinogens were administered to mice and rats to study micronucleus induction in different organs.
  • Cyclophosphamide showed a significant cytogenetic effect primarily in bone marrow cells.
  • Other tested carcinogens were effective in inducing micronuclei in various organs, including the gastrointestinal tract, liver, and lungs.

Impact:

  • Demonstrates a strong correlation between the organ specificity of mutagenic and carcinogenic effects.
  • Highlights the utility of the micronucleus test in diverse mammalian organs for carcinogen detection.
  • Provides a basis for developing more accurate methods for identifying potential carcinogens in vivo.

Related Concept Videos

In vitro Mutagenesis02:29

In vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Spontaneous and Induced Mutations01:30

Spontaneous and Induced Mutations

Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).